eMedicine Specialties > Obstetrics and Gynecology > General Obstetrics
Hyperemesis Gravidarum
Updated: Jun 19, 2009
Introduction
Background
Nausea and vomiting in pregnancy is extremely common. Hyperemesis gravidarum (HEG) is the most severe form of nausea and vomiting in pregnancy. A continuous spectrum of the severity of nausea and vomiting ranges from the nausea and vomiting that occurs in most pregnancies to the severe disorder of hyperemesis gravidarum.
Studies estimate that nausea and vomiting occurs in 50-90% of pregnancies. The nausea and vomiting associated with pregnancy usually begins by 9-10 weeks of gestation, peaks at 11-13 weeks, and resolves in most cases by 12-14 weeks. In 1-10% of pregnancies, symptoms may continue beyond 20-22 weeks.1,2
Normal nausea and vomiting may be an evolutionary protective mechanism—it may protect the pregnant woman and her embryo from harmful substances in food, such as pathogenic microorganisms in meat products and toxins in plants, with the effect being maximal during embryogenesis (the most vulnerable period of pregnancy). This is supported by studies showing that women who had nausea and vomiting were less likely to have miscarriages and stillbirth.3,4
Hyperemesis gravidarum is characterized by persistent nausea and vomiting associated with ketosis and weight loss (>5% of prepregnancy weight). Hyperemesis gravidarum may cause volume depletion, electrolytes and acid-base imbalances, nutritional deficiencies, and even death. Severe hyperemesis requiring hospital admission occurs in 0.3-2% of pregnancies.5
Pathophysiology
The physiologic basis of hyperemesis gravidarum is controversial. Hyperemesis gravidarum appears to occur as a complex interaction of biological, psychological, and sociocultural factors. The following theories have been proposed:
Hormonal changes
Women with hyperemesis gravidarum often have high hCG levels that cause transient hyperthyroidism. hCG can physiologically stimulate the thyroid gland thyroid-stimulating hormone (TSH) receptor. hCG levels peak in the first trimester. Some women with hyperemesis gravidarum appear to have clinical hyperthyroidism. However, in a larger portion (50-70%), TSH is transiently suppressed and the free thyroxine (T4) index is elevated (40-73%) with no clinical signs of hyperthyroidism, circulating thyroid antibodies, or enlargement of the thyroid. In transient hyperthyroidism of hyperemesis gravidarum, thyroid function normalizes by the middle of the second trimester without antithyroid treatment. Clinically overt hyperthyroidism and thyroid antibodies are usually absent.4,6,7,5
A report on a unique family with recurrent gestational hyperthyroidism associated with hyperemesis gravidarum showed a mutation in the extracellular domain of the TSH receptor that made it responsive to normal levels of hCG. Thus, cases of hyperemesis gravidarum with a normal hCG may be due to varying hCG isotypes.8,9
A positive correlation between the serum hCG elevation level and free T4 levels has been found, and the severity of nausea appears to be related to the degree of thyroid stimulation. hCG may not be independently involved in the etiology of hyperemesis gravidarum but may be indirectly involved by its ability to stimulate the thyroid. For these patients, hCG levels were linked to increased levels of immunoglobulin M, complement, and lymphocytes. Thus, an immune process may be responsible for increased circulating hCG or isoforms of hCG with a higher activity for the thyroid. Critics of this theory note that (1) nausea and vomiting are not usual symptoms of hyperthyroidism, (2) signs of biochemical hyperthyroidism are not universal in cases of hyperemesis gravidarum, and (3) some studies have failed to correlate the severity of symptoms with biochemical abnormalities.10,11,12
Some studies link high estradiol levels to the severity of nausea and vomiting in patients who are pregnant, while others find no correlation between estrogen levels and the severity of nausea and vomiting in pregnant women. Previous intolerance to oral contraceptives is associated with nausea and vomiting in pregnancy. Progesterone also peaks in the first trimester and decreases smooth muscle activity; however, studies have failed to show any connection between progesterone levels and symptoms of nausea and vomiting in pregnant women. Lagiou et al studied prospectively 209 women with nausea and vomiting who showed that estradiol levels were positively correlated while prolactin levels were inversely associated with nausea and vomiting in pregnancy and no correlation existed with estriol, progesterone, or sex-hormone binding globulin.13
Gastrointestinal dysfunction
The stomach pacemaker causes rhythmic peristaltic contractions of the stomach. Abnormal myoelectric activity may cause a variety of gastric dysrhythmias, including tachygastrias and bradygastrias. Gastric dysrhythmias have been associated with morning sickness. The presence of dysrhythmias was associated with nausea while normal myoelectrical activity was present in the absence of nausea. Mechanisms that cause gastric dysrhythmias include elevated estrogen or progesterone levels, thyroid disorders, abnormalities in vagal and sympathetic tone, and vasopressin secretion in response to intravascular volume perturbation. Many of these factors are present in early pregnancy. These pathophysiologic factors are hypothesized to be more severe or the gastrointestinal tract more sensitive to the neural/humoral changes in those who develop hyperemesis gravidarum.14
Hepatic dysfunction
Liver disease, usually consisting of mild serum transaminase elevation, occurs in almost 50% of patients with hyperemesis gravidarum. Impairment of mitochondrial fatty acid oxidation (FAO) has been hypothesized to play a role in the pathogenesis of maternal liver disease associated with hyperemesis gravidarum. It has been suggested that women heterozygous for FAO defects develop hyperemesis gravidarum associated with liver disease while carrying fetuses with FAO defects due to accumulation of fatty acids in the placenta and subsequent generation of reactive oxygen species. Alternatively, it is possible that starvation leading to peripheral lipolysis and increased load of fatty acids in maternal-fetal circulation, combined with reduced capacity of the mitochondria to oxidize fatty acids in mothers heterozygous for FAO defects, can also cause hyperemesis gravidarum and liver injury while carrying nonaffected fetuses.
Lipid alterations
Jarnfelt-Samsioe et al found higher levels of triglycerides, total cholesterol, and phospholipids in women with hyperemesis gravidarum compared with matched, nonvomiting, pregnant and nonpregnant controls. This may be related to the abnormalities in hepatic function in pregnant women. However, Ustun et al found decreased levels of total cholesterol, LDL cholesterol, apoA and apoB in women with hyperemesis gravidarum compared with controls.15,16
Infection
Helicobacter pylori is a bacterium found in the stomach that may aggravate nausea and vomiting in pregnancy. Studies have found conflicting evidence of the role of H pylori in hyperemesis gravidarum. Recent studies in the United States have not shown association with hyperemesis gravidarum. However, persistent nausea and vomiting beyond the second trimester may be due to an active peptic ulcer caused by H pylori infection.17,18
Vestibular and olfaction
Hyperacuity of the olfactory system may be a contributing factor to nausea and vomiting during pregnancy. Many pregnant women report the smell of cooking food, particularly meats, as triggers to nausea. Striking similarities between hyperemesis gravidarum and motion sickness suggest that unmasking of subclinical vestibular disorders may account for some cases of hyperemesis gravidarum.19,20
Biochemical research
Hyperemesis gravidarum is associated with overactivation of sympathetic nerves and enhanced production of tumor necrosis factor (TNF)-alpha.21 Increased adenosine levels have also been noted; since adenosine is an established suppressor of excessive sympathetic nerves activation and cytokine production, the increase in plasma adenosine in hyperemesis gravidarum may be modulatory.22 Trophoblast-derived cytokines have been reported to induce secretion of hCG.
Immunoglobulins C3 and C4 and lymphocyte counts are significantly higher in women with hyperemesis gravidarum. T-helper 1/T-helper 2 balance is decreased in women with hyperemesis gravidarum, which results in increased humoral immunity. Increased fetal DNA has been found in the maternal plasma of women with hyperemesis gravidarum, and the increased DNA is speculated to be derived from trophoblasts that have been destroyed by the hyperactive maternal immune system. Thus, hyperemesis gravidarum may be mediated by immunologic aberrations in pregnancy.23,24,25,26
Psychological issues
Some cases of hyperemesis gravidarum may represent psychiatric illnesses, including Munchausen syndrome, conversion or somatization disorder, or major depression. They may occur under situations of stress or ambivalence surrounding the pregnancy. It appears that psychologic responses can interact and exacerbate the physiology of nausea and vomiting during pregnancy. Most likely, physiological changes associated with pregnancy interact with each woman's psychologic state and cultural values. However, hyperemesis gravidarum is usually not the result of a psychologic illness. It is frequently the cause of, as opposed to the result of, psychologic stress.27,28,29
Frequency
United States
Of all pregnancies, 0.3-2% are affected by hyperemesis gravidarum (approximately 5 per 1000 pregnancies).
International
Hyperemesis gravidarum appears to be more common in westernized industrialized societies and urban areas than rural areas.
Mortality/Morbidity
Hyperemesis gravidarum was a significant cause of maternal death before 1940. In Great Britain, mortality decreased from 159 deaths per million births from 1931-1940 to 3 deaths per million births from 1951-1960. Charlotte Brontë is thought to have died of hyperemesis gravidarum in 1855. In the United States, 7 deaths from hyperemesis gravidarum were reported in the 1930s. Today, although hyperemesis gravidarum is still associated with significant morbidity, it is still a rare cause of maternal mortality.
- Many hours of productive work are lost because of nausea and vomiting during pregnancy. Nearly 50% of employed women believe that their work is affected, and up to 25% require time off from work.
- Hyperemesis gravidarum is a debilitating illness that can cause severe suffering, which profoundly affects both patients and their families. In about half of the women there is an adverse effect on spousal relationships, and 55% have feelings of depression. In one study of 140 women with hyperemesis gravidarum, 27% required multiple hospitalizations. The financial burden of hyperemesis gravidarum on the American health system has been estimated as approximately $130 million dollars per year, excluding physician fees.
- Women with hyperemesis gravidarum who have a low pregnancy weight gain (<15.4 lb or 7 kg) have increased risk for delivering neonates of low birth weight, delivering neonates who are small for gestational age, preterm delivery, and a 5-minute Apgar score of less than 7.
Race
No clear racial predominance is noted for hyperemesis gravidarum.
- Hyperemesis gravidarum is less common in American Indian and Eskimo populations.
- Hyperemesis gravidarum is less common in African and some Asian populations (but not industrialized Japan).
Sex
Hyperemesis gravidarum affects females.
Age
The risk of hyperemesis gravidarum appears to decrease with advanced maternal age.
Clinical
History
- The defining symptoms of hyperemesis gravidarum are gastrointestinal in nature and include nausea and vomiting.
- Other common symptoms include ptyalism (excessive salivation), fatigue, weakness, and dizziness.
- Patients may experience the following:
- Sleep disturbance
- Hyperolfaction
- Dysgeusia
- Decreased gustatory discernment
- Depression
- Anxiety
- Irritability
- Mood changes
- Decreased concentration
- When obtaining history from the patient, discuss present symptoms. Obtain information pertaining to the timing, onset, severity, pattern, and alleviating and exacerbating factors (eg, relationship to meals, medications, prenatal vitamins, stress, other triggers).
- A thorough review of systems for any symptoms that might suggest other gastrointestinal, renal, endocrine, and central nervous system disorders is vital.
- Review past medical history, placing emphasis on past medical conditions, surgeries, medications, allergies, adverse drug reactions, family history, social history (including support system), employment, habits, and diet.
- Obtaining a thorough gynecologic history of symptoms, such as vaginal bleeding or spotting, past pregnancies, past use of oral contraceptives, and response to oral contraceptives used, is important.
Physical
- The physical examination is usually unremarkable in patients with hyperemesis gravidarum.
- The physical examination findings may be more helpful if the patient has unusual complaints suggestive of other disorders (eg, bleeding, abdominal pain).
- Pay attention to the vital signs, including standing and lying blood pressure and pulse, volume status (eg, mucous membrane condition, skin turgor, neck veins, mental status), general appearance (eg, nutrition, weight), thyroid examination findings, abdominal examination findings, cardiac examination findings, and neurologic examination findings.
Causes
In a review of 1,301 cases of hyperemesis gravidarum from Canada, Fell et al showed that medical complications of hyperthyroid disorders, psychiatric illness, previous molar disease, gastrointestinal disorders, pregestational diabetes, and asthma were significantly independent risk factors for hyperemesis gravidarum, whereas maternal smoking and maternal age older than 30 years decreased the risk. Pregnancies with female fetuses and multiple fetuses were also at increased risk.30,31
In some studies, women from low to middle socioeconomic class, women with lower levels of education, women with previous pregnancies with nausea and vomiting, women in their first pregnancy, and women with previous intolerance to oral contraceptives more commonly experience nausea and vomiting during pregnancy. Nausea and vomiting during pregnancy is also more common with multiple-gestation pregnancies.
Other factors that have been proposed include ethnicity, occupational status, fetal anomalies, increased body weight, nausea and vomiting in a prior pregnancy, history of infertility, interpregnancy interval, corpus luteum in right ovary, and prior intolerance to oral contraceptives.
- Risk factors for hyperemesis gravidarum may include the following:
- Previous pregnancies with hyperemesis gravidarum
- Greater body weight
- Multiple gestations
- Trophoblastic disease
- Nulliparity
- Cigarette smoking is associated with a decreased risk for hyperemesis gravidarum.
More on Hyperemesis Gravidarum |
Overview: Hyperemesis Gravidarum |
| Differential Diagnoses & Workup: Hyperemesis Gravidarum |
| Treatment & Medication: Hyperemesis Gravidarum |
| Follow-up: Hyperemesis Gravidarum |
| References |
| Next Page » |
References
Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: A prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. Apr 2000;182(4):931-7. [Medline].
Bailit JL. Hyperemesis gravidarium: Epidemiologic findings from a large cohort. Am J Obstet Gynecol. Sep 2005;193(3 Pt 1):811-4. [Medline].
Sherman PW, Flaxman SM. Nausea and vomiting of pregnancy in an evolutionary perspective. Am J Obstet Gynecol. May 2002;186(5 Suppl Understanding):S190-7. [Medline].
Creasy RK, Resnik R. gastrointestinal disease in pregnancy. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine, Principles and Practice. 5th ed. Philadelphia, Pa: WB Saunders; 2004:1109-22.
Goodwin TM. Hyperemesis gravidarum. Obstet Gynecol Clin North Am. Sep 2008;35(3):401-17, viii.
Kuscu NK, Koyuncu F. Hyperemesis gravidarum: current concepts and management. Postgrad Med J. Feb 2002;78(916):76-9. [Medline].
Goodwin TM, Nwankwo OA, O'Leary LD, et al. The first demonstration that a subset of women with hyperemesis gravidarum has abnormalities in the vestibuloocular reflex pathway. Am J Obstet Gynecol. Oct 2008;199(4):417.e1-9. [Medline].
Rodien P, Jordan N, Lefevre A, et al. Abnormal stimulation of the thyrotrophin receptor during gestation. Hum Reprod Update. Mar-Apr 2004;10(2):95-105. [Medline].
Panesar NS, Li CY, Rogers MS. Are thyroid hormones or hCG responsible for hyperemesis gravidarum? A matched paired study in pregnant Chinese women. Acta Obstet Gynecol Scand. Jun 2001;80(6):519-24. [Medline].
Murata T, Suzuki S, Takeuchi T, et al. Relation between plasma adenosine and serum TSH levels in women with hyperemesis gravidarum. Arch Gynecol Obstet. Mar 2006;273(6):331-6. [Medline].
Leylek OA, Toyaksi M, Erselcan T, et al. Immunologic and biochemical factors in hyperemesis gravidarum with or without hyperthyroxinemia. Gynecol Obstet Invest. 1999;47(4):229-34. [Medline].
Hershman JM. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid. Jul 1999;9(7):653-7. [Medline].
Lagiou P, Tamimi R, Mucci LA, et al. Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: a prospective study. Obstet Gynecol. Apr 2003;101(4):639-44. [Medline].
Koch KL. Gastrointestinal factors in nausea and vomiting of pregnancy. Am J Obstet Gynecol. May 2002;186(5 Suppl Understanding):S198-203. [Medline].
Jarnfelt-Samsioe A, Eriksson B, Waldenstrom J, et al. Serum bile acids, gamma-glutamyltransferase and routine liver function tests in emetic and nonemetic pregnancies. Gynecol Obstet Invest. 1986;21(4):169-76. [Medline].
Ustun Y, Engin-Ustun Y, Dokmeci F, et al. Serum concentrations of lipids and apolipoproteins in normal and hyperemetic pregnancies. J Matern Fetal Neonatal Med. May 2004;15(5):287-90. [Medline].
Kocak I, Akcan Y, Ustun C. Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Obstet Gynecol Sur. 2000;55 (4):198-9.
Lee RH, Pan VL, Wing DA. The prevalence of Helicobacter pylori in the Hispanic population affected by hyperemesis gravidarum. Am J Obstet Gynecol. Sep 2005;193(3 Pt 2):1024-7. [Medline].
Black FO. Maternal susceptibility to nausea and vomiting of pregnancy: is the vestibular system involved?. Am J Obstet Gynecol. May 2002;186(5 Suppl Understanding):S204-9. [Medline].
Heinrichs L. Linking olfaction with nausea and vomiting of pregnancy, recurrent abortion, hyperemesis gravidarum, and migraine headache. Am J Obstet Gynecol. May 2002;186(5 Suppl Understanding):S215-9. [Medline].
Kaplan PB, Gucer F, Sayin NC, et al. Maternal serum cytokine levels in women with hyperemesis gravidarum in the first trimester of pregnancy. Fertil Steril. Mar 2003;79(3):498-502. [Medline].
Kiyokawa Y, Yoneyama Y. Relationship between adenosine and T-helper 1/T-helper 2 balance in hyperemesis gravidarum. Clin Chim Acta. Aug 2006;370(1-2):137-42. [Medline].
Sekizawa A, Sugito Y, Iwasaki M, et al. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin Chem. Dec 2001;47(12):2164-5. [Medline].
Sugito Y, Sekizawa A, Farina A, et al. Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. Clin Chem. Oct 2003;49(10):1667-9. [Medline].
Yoneyama Y, Suzuki S, Sawa R, et al. Plasma adenosine concentrations increase in women with hyperemesis gravidarum. Clin Chim Acta. Feb 2005;352(1-2):75-9. [Medline].
Yoneyama Y, Suzuki S, Sawa R, et al. The T-helper 1/T-helper 2 balance in peripheral blood of women with hyperemesis gravidarum. Am J Obstet Gynecol. Dec 2002;187(6):1631-5. [Medline].
Simpson SW, Goodwin TM, Robins SB, et al. Psychological factors and hyperemesis gravidarum. J Womens Health Gend Based Med. Jun 2001;10(5):471-7. [Medline].
Buckwalter JG, Simpson SW. Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol. May 2002;186(5 Suppl Understanding):S210-4. [Medline].
Morrow GR, Roscoe JA, Hickok JT, et al. Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer. Mar 2002;10(2):96-105. [Medline].
Fell DB, Dodds L, Joseph KS, et al. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol. Feb 2006;107(2 Pt 1):277-84. [Medline].
Dodds L, Fell DB, Joseph KS, et al. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol. Feb 2006;107(2 Pt 1):285-92. [Medline].
Hay JE. Liver disease in pregnancy. Hepatology. Mar 2008;47(3):1067-76. [Medline].
Tan JY, Loh KC, Yeo GS, et al. Transient hyperthyroidism of hyperemesis gravidarum. BJOG. Jun 2002;109(6):683-8. [Medline].
Simon EP, Schwartz J. Medical hypnosis for hyperemesis gravidarum. Birth. Dec 1999;26(4):248-54. [Medline].
Rosen T, de Veciana M, Miller HS, et al. A randomized controlled trial of nerve stimulation for relief of nausea and vomiting in pregnancy. Obstet Gynecol. Jul 2003;102(1):129-35. [Medline].
[Best Evidence] Borrelli F, Capasso R, Aviello G, et al. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol. Apr 2005;105(4):849-56. [Medline].
Safari HR, Alsulyman OM, Gherman RB, et al. Experience with oral methylprednisolone in the treatment of refractory hyperemesis gravidarum. Am J Obstet Gynecol. May 1998;178(5):1054-8. [Medline].
Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. Jun 11 2009;2528-2435.
Holmgren C, Aagaard-Tillery KM, Silver RM, et al. Hyperemesis in pregnancy: an evaluation of treatment strategies with maternal and neonatal outcomes. Am J Obstet Gynecol. Jan 2008;198(1):56.e1-4. [Medline].
Poursharif B, Korst LM, Macgibbon KW, et al. Elective pregnancy termination in a large cohort of women with hyperemesis gravidarum. Contraception. Dec 2007;76(6):451-5. [Medline].
ACOG. ACOG (American College of Obstetrics and Gynecology) Practice Bulletin: nausea and vomiting of pregnancy. Obstet Gynecol. Apr 2004;103(4):803-14. [Medline].
Goodwin TM. Nausea and vomiting of pregnancy: an obstetric syndrome. Am J Obstet Gynecol. May 2002;186(5 Suppl Understanding):S184-9. [Medline].
Hsu JJ, Clark-Glena R, Nelson DK, et al. Nasogastric enteral feeding in the management of hyperemesis gravidarum. Obstet Gynecol. Sep 1996;88(3):343-6. [Medline].
Järnfelt-Samsioe A, Eriksson B, Mattsson LA, et al. Serum lipids and lipoproteins in pregnancies associated with emesis gravidarum. Gynecol Endocrinol. Mar 1987;1(1):51-60. [Medline].
Larimore WL, Petrie KA. Drug use during pregnancy and lactation. Prim Care. Mar 2000;27(1):35-53. [Medline].
Scott JR. . Normal Pregnancy and Prenatal Care, Medical and Surgical Complications of Pregnancy. In: Danforth DN, De Saia PJ, Hammond CB, Scott JR, eds. Danforth's Obstetrics and Gynecology. 127-129. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008:282-286.
Further Reading
Keywords
hyperemesis gravidarum, HEG, nausea in pregnancy, vomiting in pregnancy, morning sickness, difficult pregnancy, pregnancy complications, ketosis, pregnancy, pregnancy weight loss, Helicobacter pylori, H pylori
Overview: Hyperemesis Gravidarum